Patient Care Patient with Stage 4 ALK-Positive Lung Cancer Hasn’t Skipped a Beat, Thanks to Targeted Therapy Nov. 4, 2021 Facebook Twitter LinkedIn Email Skip breadcrumb URMC Home Newsroom News Patient with Stage 4 ALK-Positive Lung Cancer Hasn’t Skipped a Beat, Thanks to Targeted Therapy
